Related Experiment Video
Updated: Jul 5, 2025
08:52
Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
14.0K
Recent Progress in Anti-Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation
Lan Yao1, Xiang Zhu1, Yunyi Shan1
1State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198, P. R. China.
Small (Weinheim an Der Bergstrasse, Germany)
|January 25, 2024
Summary
Nanodrugs targeting tumor microenvironment (TME) redox homeostasis disrupt abnormal redox states, promoting cancer cell death. This approach offers a promising strategy for novel anti-tumor therapies by modulating TME redox balance.
Area of Science:
- Biochemistry
- Oncology
- Nanotechnology
Background:
- Tumor cell growth is influenced by the abnormal redox status of the tumor microenvironment (TME).
- Redox reactions are fundamental to tumor energy metabolism.
- Disrupting TME redox homeostasis is a key strategy in anti-tumor nanomedicine.
Purpose of the Study:
- To review the latest research on nanodrugs for anti-tumor therapy.
- To highlight strategies for regulating TME redox balance using nanodrugs.
- To discuss the potential of TME redox modulation in cancer treatment.
Main Methods:
- Review of recent studies on nanodrugs and TME redox modulation.
- Analysis of therapeutic strategies targeting oxidants and reductants in TME.
- Evaluation of nanodrugs' effectiveness in disrupting redox homeostasis.
Main Results:
- Nanodrugs can effectively modulate TME redox levels through various strategies.
- Disruption of TME redox homeostasis leads to tumor cell death.
- Targeting redox balance shows significant anti-tumor efficiency.
Conclusions:
- Nanodrugs targeting TME redox offer a promising avenue for cancer therapy.
- Further research into TME redox states and nanomaterials will drive clinical applications.
- Developing nanodrugs based on TME redox regulation is expected to advance cancer treatment.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
13.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.4K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K